CORT - Corcept Therapeutics Inc
IEX Last Trade
35.285
0.145 0.411%
Share volume: 689,637
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$35.14
0.15
0.41%
Summary score
59%
Profitability
72%
Dept financing
5%
Liquidity
75%
Performance
55%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
5.57%
Return on assets
5.23%
Return on sales
27.53%
Return on invested capital
-89.76%
Total debt ratio
13.01%
Debt ratio change over timeo
-0.79%
Current Ratio
7.21%
Quick Ratio
7.12%
Cash Position Ratio
6.34%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
6%
Return on assets
4.96%
Return on sales
22.61%
Return on invested capital
62.03%
Total debt ratio
18.45%
Debt ratio change over timeo
-0.7%
Current Ratio
4.67%
Quick Ratio
4.6%
Cash Position Ratio
3.84%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
5.95%
Return on assets
4.98%
Return on sales
21.73%
Return on invested capital
67.01%
Total debt ratio
16.56%
Debt ratio change over time
-0.75%
Current Ratio
5.57%
Quick Ratio
5.48%
Cash Position Ratio
4.7%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-89.5%
Return on assets
-89.86%
Return on sales
-44.6%
Return on invested capital
-3.24%
Total debt ratio
-79.48%
Debt ratio change over time
-0.79%
Current Ratio
13.19%
Quick Ratio
13%
Cash Position Ratio
11.56%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | CORT | LLY | NVO | JNJ |
---|---|---|---|---|
Return on equity | 5.57% | 17.78% | 0% | 7.65% |
Return on assets | 5.23% | 4.21% | 0% | 3.28% |
Return on sales | 27.53% | 28.35% | 0% | 25.79% |
Return on invested capital | -89.76% | 9.83% | 0% | 7.58% |
Profitability | 57% | 95% | 0% | 68% |
Total debt ratio | 13.01% | 82.4% | 0% | 60.04% |
Debt ratio change over time | -0.79% | -5.2% | 0% | -33.96% |
Dept financing | 4% | 25% | 25% | 18% |
Current Ratio | 4.67% | 1.11% | 0% | 1.15% |
Quick Ratio | 4.6% | 0.86% | 0% | 0.91% |
Cash Position Ratio | 3.84% | 0.12% | 0% | 0.51% |
Liquididy | 75% | 8% | 0% | 10% |
Short-term ratios | CORT | LLY | NVO | JNJ |
---|---|---|---|---|
Return on equity | 6% | 12.44% | 0% | 13.41% |
Return on assets | 4.96% | 4.94% | 0% | 3.06% |
Return on sales | 22.61% | 32.95% | 0% | 26.07% |
Return on invested capital | 62.03% | 10.2% | 0% | 13.98% |
Profitability | 78% | 77% | 0% | 66% |
Total debt ratio | 18.45% | 81.25% | 0% | 58.96% |
Debt ratio change over time | -0.7% | -57.62% | 0% | 7.09% |
Dept financing | 6% | 25% | 0% | 43% |
Current Ratio | 4.67% | 1.11% | 0% | 1.15% |
Quick Ratio | 4.6% | 0.86% | 0% | 0.91% |
Cash Position Ratio | 3.84% | 0.12% | 0% | 0.51% |
Liquididy | 75% | 11% | 0% | 14% |